About US
Contact us
-
China's Ministry of Commerce Grants Clearance for Merger of BMP Sunstone and Sanofi-aventis SubsidiaryNEW YORK, Jan. 27, 2011 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) announced today that China's Ministry of Commerce granted clearance for the transaction in which sanofi-a2011/1/28
-
FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer riskGlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avo2011/1/28
-
Merck Canada Invests $5 Million in Quebec Consortium for Drug Discovery to Support Biopharmaceutical ResearchMONTREAL, Jan. 26 /CNW Telbec/ - Merck Canada has renewed its partnership with the Quebec Consortium for Drug Discovery (CQDM) by investing a further $5 million over five years in the organization so2011/1/27
-
GlaxoSmithKline Begins Melanoma Drug ResearchGlaxoSmithKline has commenced Phase III studies of two investigational agents for patients with advanced melanoma. The studies will test the efficacy and safety of GSK2118436 and GSK1120212 to dete2011/1/26
-
Mylan enters settlement agreement with Pfizer for Caduet Tablets litigationMylan Inc. (Nasdaq: MYL) today announced that it has entered into a settlement agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, 2.5 mg/10, 2.5 mg/20 mg, 2.5 mg/40 mg, 52011/1/25
-
Sanofi-aventis acquires world-wide license for ADC productsOxford BioTherapeutics (OBT) today announces that sanofi-aventis has acquired an exclusive world-wide license to one of OBT's internal preclinical antibody programs. sanofi-aventis intends to use t2011/1/25
-
China Shenghuo's Lixuwang product recieves Chinese Well-Known Trademark HonorChina Shenghuo Pharmaceutical Holdings, Inc., a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine (TCM), nutritional s2011/1/24
-
Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approvalBayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously that clin2011/1/24
-
GSK, Valeant receive European CHMP positive opinion for TrobaltGlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) h2011/1/23
-
Merck and Lead Discovery to Develop Anti-Cancer CompoundsMerck Serono, a division of Merck, has announced a cooperation agreement with the Lead Discovery Center (LDC), a small molecule drug discovery spin-off of Max Planck Innovation, to promote the discove2011/1/23